Reshape customer story · Jul 2026
Mascoma uses Reshape to run ten simultaneous 96-well plates and get richer MIC data, improving throughput and decision quality for food, feed, and fuel testing.
Robots that automate the everyday tasks of microbiologists.
Company research
Public company, workplace, funding, and market signals
Overview
Reshape Biotech is a Copenhagen-based biotechnology research company building an AI operating system for microbiology labs. Its platform combines lab automation hardware, computer vision, and AI to automate image capture, turn experiments into structured data, and accelerate R&D and QC workflows across biotech, food, agriculture, industrial, and personal care use cases.
Primary product
AI operating system for microbiology labs (Reshape platform)
Founded
2018
Headquarters
Østbanegade 55, 1. floor, 2100 Kbh Ø, Copenhagen, Denmark
Team size
40-50
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
Lab automation / microbiology imaging AI
Offices
Østbanegade 55, 1. floor, 2100 Kbh Ø, Copenhagen, Denmark
Viborggade 70, Copenhagen, Denmark
Copenhagen, Hovedstaden, Denmark
Business model
B2B enterprise hardware + software
Platform subscription / software licensing
Implementation and support services
Funding
Stage
Series A
Total raised
$29.2M
Latest round
Series A · Apr 2024
Latest amount
$20M
People & investors
Leadership
CEO & Co-founder
Chief Customer Officer, Co-founder
Co-founder
Chief Operating Officer
Scientific Solutions & Business Development Lead
Lead Data Scientist
Work & culture
Lean, ambitious, multi-disciplinary startup culture centered on trust, transparency, accountability, and rapid iteration. The company emphasizes strong collaboration across microbiology, computer vision, hardware, software, and commercial teams, with a Copenhagen HQ and a strong preference for hands-on team fit.
Work style
Flexible
Compensation
Public job postings mention competitive compensation, commission for sales roles, and equity / warrant upside; some postings also mention a warrant program. No public salary bands were found.
Benefits
Flexible working hours
Competitive compensation
Equity / warrant program
Free lunch
Free coffee / tea
Snacks in the office
Pet friendly
Paid holiday
Social gatherings
Near public transit
Product & market
Pricing
Custom quote / demo-led enterprise sales; no public pricing listed.
Differentiators
- —Full-stack hardware + software + AI platform
- —Domain-specific microbiology workflows for R&D and QC
- —Objective computer-vision analysis instead of manual scoring
- —High-throughput time-lapse imaging with structured data capture
- —Cloud collaboration plus API/LIMS/ELN integration
- —Audit trails and compliance-oriented workflows
- —Pretrained models and continuously improving dataset scale
Technology
computer vision
machine learning
AI models
robotics
custom imaging and lighting hardware
high-resolution time-lapse imaging
cloud platform
API
LIMS/ELN integrations
structured data and audit trails
Python
JavaScript
TypeScript
React
Django
Docker
Terraform
Linux
Customers
Syngenta
University of Oxford
Carlsberg Research Laboratory
Imperial College London
Mascoma (Lallemand)
Aviagen
Food Brewer
Ventera Bio
DTU Biosustain
Novozymes
FMCG company
Competitors
Automata
Opentrons
Strateos (Transcriptic)
Sartorius
Eppendorf
Thermo Fisher Scientific
Scale & contact
Estimated revenue
$1M-$10M
Estimated monthly visits
6.1K
Traffic estimate as of Jun 2026
Latest news
Reshape blog · May 2026
Reshape announced upgrades to its High-throughput Imaging Device, emphasizing higher throughput, improved usability, compliance, and LIMS/ELN-ready audit trails.
Reshape LinkedIn · Mar 2026
Reshape joined a 4-year Innovation Fund Denmark-backed project with DTU and Danish startup partners to accelerate fungal innovation for food, medicine, and agriculture.
Reshape blog · Dec 2025
Reshape introduced an Organism Library that aggregates time-of-appearance data across jobs and conditions, turning experimental history into reusable insights.
Reshape blog · Feb 2025
Reshape announced a $20M Series A led by Astanor Ventures with R7, ACME, Y Combinator, Nicholas Francis, and Per Falholt participating; the funds were aimed at US expansion and hiring.
Jobs and careers at Reshape Biotech
0 jobs at Reshape Biotech
No open positions
Check back later for new openings